(Q73893853)
English
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SA
scientific article published on 01 June 1997
Statements
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK) (English)
B Thürlimann
M Castiglione
S F Hsu-Schmitz
H Bonnefoi
M F Fey
R Morant
T Löhnert